TrialThe Journal of infectious diseases2012

A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.

Timothy J Wilkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.